Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P E Spronk

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
The Netherlands Journal of Medicine|November 1, 1996
17 alpha-Hydroxylase deficiency; a rare cause of chronic hypertensionP E Spronk, F Bergkamp, R W ten Kate
Annals of the Rheumatic Diseases|June 19, 2001
Severe atherosclerotic changes, including aortic occlusion, associated with hyperhomocysteinaemia and antiphospholipid antibodiesP E Spronk, E H Overbosch, N H Schut
The Netherlands Journal of Medicine|July 5, 2001
Eosinophilic tubulo-interstitial nephritis associated with iridocyclitis and thyreoiditisP E Spronk, J J Weening, N H Schut
Lupus|April 1, 1995
Serological markers of disease activity in systemic lupus erythematosusP E Spronk, P C Limburg, C G Kallenberg
Annals of the Rheumatic Diseases|March 1, 1992
Patients with systemic lupus erythematosus and Jaccoud's arthropathy: a clinical subset with an increased C reactive protein response?P E Spronk, E J ter Borg, C G Kallenberg
Minerva Anestesiologica|November 27, 2009
Evidence lost to treatment of critically-ill patients?M J Schultz, P E Spronk, B Afessa, et al.
Journal of Clinical Monitoring and Computing|May 15, 2021
Electrolyte monitoring during regional citrate anticoagulation in continuous renal replacement therapyC Warnar, E Faber, P A Katinakis, et al.
Clinical and Experimental Immunology|July 1, 1993
B cell activation in clinically quiescent systemic lupus erythematosus (SLE) is related to immunoglobulin levels, but not to levels of anti-dsDNA, nor to concurrent T cell activationP E Spronk, B T vd Gun, P C Limburg, et al.
Nederlands Tijdschrift Voor Geneeskunde|February 26, 2005
[Lithium, a potentially dangerous drug]M S S Yo, J H Rommes, P E Spronk, et al.
Clinical and Experimental Immunology|October 1, 1992
Plasma concentration of IL-6 in systemic lupus erythematosus; an indicator of disease activity?P E Spronk, E J ter Borg, P C Limburg, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
The Netherlands Journal of Medicine|November 1, 1996
17 alpha-Hydroxylase deficiency; a rare cause of chronic hypertensionP E Spronk, F Bergkamp, R W ten Kate
Annals of the Rheumatic Diseases|June 19, 2001
Severe atherosclerotic changes, including aortic occlusion, associated with hyperhomocysteinaemia and antiphospholipid antibodiesP E Spronk, E H Overbosch, N H Schut
The Netherlands Journal of Medicine|July 5, 2001
Eosinophilic tubulo-interstitial nephritis associated with iridocyclitis and thyreoiditisP E Spronk, J J Weening, N H Schut
Lupus|April 1, 1995
Serological markers of disease activity in systemic lupus erythematosusP E Spronk, P C Limburg, C G Kallenberg
Annals of the Rheumatic Diseases|March 1, 1992
Patients with systemic lupus erythematosus and Jaccoud's arthropathy: a clinical subset with an increased C reactive protein response?P E Spronk, E J ter Borg, C G Kallenberg
Minerva Anestesiologica|November 27, 2009
Evidence lost to treatment of critically-ill patients?M J Schultz, P E Spronk, B Afessa, et al.
Journal of Clinical Monitoring and Computing|May 15, 2021
Electrolyte monitoring during regional citrate anticoagulation in continuous renal replacement therapyC Warnar, E Faber, P A Katinakis, et al.
Clinical and Experimental Immunology|July 1, 1993
B cell activation in clinically quiescent systemic lupus erythematosus (SLE) is related to immunoglobulin levels, but not to levels of anti-dsDNA, nor to concurrent T cell activationP E Spronk, B T vd Gun, P C Limburg, et al.
Nederlands Tijdschrift Voor Geneeskunde|February 26, 2005
[Lithium, a potentially dangerous drug]M S S Yo, J H Rommes, P E Spronk, et al.
Clinical and Experimental Immunology|October 1, 1992
Plasma concentration of IL-6 in systemic lupus erythematosus; an indicator of disease activity?P E Spronk, E J ter Borg, P C Limburg, et al.
Pageof 4